Cargando…

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study

BACKGROUND: We previously observed in a cross-sectional analysis that frequencies of amyloid and neurodegeneration biomarker states varied greatly by age among cognitively non-impaired participants, suggesting dynamic within-person processes. Our objective in this longitudinal study was to estimate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jack, Clifford R., Therneau, Terry M., Wiste, Heather J., Weigand, Stephen D., Knopman, David S., Lowe, Val J., Mielke, Michelle M., Vemuri, Prashanthi, Roberts, Rosebud O., Machulda, Mary M., Senjem, Matthew L., Gunter, Jeffrey L., Rocca, Walter A., Petersen, Ronald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784263/ https://www.ncbi.nlm.nih.gov/pubmed/26597325 http://dx.doi.org/10.1016/S1474-4422(15)00323-3

Ejemplares similares

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study
por: Jack, Clifford R., et al.
Publicado: (2017)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

Brain amyloid, cortical thickness, and changes in activities of daily living
por: Vassilaki, Maria, et al.
Publicado: (2020)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Predicting future rates of tau accumulation on PET
por: Jack, Clifford R, et al.
Publicado: (2020)

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease
por: Jack, Clifford R., et al.
Publicado: (2010)

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology
por: Ramanan, Vijay K., et al.
Publicado: (2021)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

A computational model of neurodegeneration in Alzheimer’s disease
por: Jones, D., et al.
Publicado: (2022)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
por: Neth, Bryan J., et al.
Publicado: (2020)

Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration
por: Zeydan, Burcu, et al.
Publicado: (2018)

Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech
por: Whitwell, Jennifer L., et al.
Publicado: (2016)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

(1)H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
por: Nedelska, Zuzana, et al.
Publicado: (2017)

Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?()
por: Whitwell, Jennifer L., et al.
Publicado: (2013)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
por: Jack, Clifford R., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3kk04ablko7i9plfoj6dd410v4